Literature DB >> 11686001

NAD(P)H oxidases and their relevance to atherosclerosis.

D Sorescu1, K Szöcs, K K Griendling.   

Abstract

Studies performed during the last decade have identified NAD(P)H oxidases unique to nonphagocytic vascular cells. The reactive oxygen species released from these enzymes regulate fundamental cellular functions such as growth (hyperplastic or hypertrophic), endothelial dysfunction, migration and inflammation, which have been demonstrated to play a role in atherogenesis. Evidence from experimental animal and human studies implicate the nonphagocytic NAD(P)H oxidases in multiple aspects of atherogenesis, suggesting that these enzymes may be important determinants of the course of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686001     DOI: 10.1016/s1050-1738(01)00097-4

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  19 in total

1.  A modified sesamol derivative inhibits progression of atherosclerosis.

Authors:  Zhekang Ying; Nisharahmed Kherada; Thomas Kampfrath; Georgeta Mihai; Orlando Simonetti; Rajagopal Desikan; Karuppaiyah Selvendiran; Qinghua Sun; Ouiliana Ziouzenkova; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-23       Impact factor: 8.311

2.  NOX-mediated impairment of PDGF-induced DNA synthesis in peripheral blood lymphocytes of children with idiopathic nephrotic syndrome.

Authors:  Amal Al-Eisa; Gursev S Dhaunsi
Journal:  Pediatr Res       Date:  2017-06-14       Impact factor: 3.756

3.  Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model.

Authors:  Bertrand Collin; David Busseuil; Marianne Zeller; Caroline Perrin; Olivier Barthez; Laurence Duvillard; Catherine Vergely; Marc Bardou; Monique Dumas; Yves Cottin; Luc Rochette
Journal:  Mol Cell Biochem       Date:  2006-07-27       Impact factor: 3.396

Review 4.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 5.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

Review 6.  Perspectives and challenges of antioxidant therapy for atrial fibrillation.

Authors:  Iveta Gasparova; Peter Kubatka; Radka Opatrilova; Martin Caprnda; Slavomira Filipova; Luis Rodrigo; Leone Malan; Ioana Mozos; Miroslava Rabajdova; Vladimir Nosal; Nazarii Kobyliak; Vanda Valentova; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-11-29       Impact factor: 3.000

Review 7.  The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias.

Authors:  Shahriar Iravanian; Samuel C Dudley
Journal:  Heart Rhythm       Date:  2008-03-04       Impact factor: 6.343

8.  Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications.

Authors:  Assunta Pandolfi; Elena Anna De Filippis
Journal:  Genes Nutr       Date:  2007-10-17       Impact factor: 5.523

9.  Lipoic acid effects on established atherosclerosis.

Authors:  Zhekang Ying; Nisharahmed Kherada; Britten Farrar; Thomas Kampfrath; Yiucho Chung; Orlando Simonetti; Jeffrey Deiuliis; Rajagopal Desikan; Bobby Khan; Frederick Villamena; Qinghua Sun; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  Life Sci       Date:  2009-11-26       Impact factor: 5.037

10.  Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production.

Authors:  Antonella De Angelis; Barbara Rinaldi; Annalisa Capuano; Francesco Rossi; Amelia Filippelli
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.